Stockchase Opinions

Mike S. Newton, CIM FCSI Life Technologies Corporation LIFE-Q PAST TOP PICK Aug 14, 2012

(A Top Pick Sept 13/11. Up 19.62%.) Biotechnology, biopharmaceutical. Currently they are doing a DNA sequencing kit that is under $1000 and takes 2 weeks. Has considerable cash flow and great metrics. Wouldn’t be surprised if it got taken out by a private equity firm.

$46.690

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

TOP PICK
Trades at only 10 times earnings. Largest life sciences in S&P 500. Nice looking chart. In 90% of all lab work, from forensic to agricultural. High growth profile that is just starting to take off. Excellent earnings.
PAST TOP PICK
(A Top Pick Oct 27/09. Up 0.83%.) Got stopped out. Still a good buy.
TOP PICK
Owned in the past and it did him very well. One of the best and largest life sciences in the S&P 500. Once of the best assets in that space. A similar company was bought for a 40% premium. Government safety program, diagnostic equipment.
PAST TOP PICK
(A Top Pick Sept 13/11. Up 23.96%.) Came out in January with a very cheap product that does DNA sequencing. Continues to be a name that is suggested as a takeout candidate.
PAST TOP PICK

(Top Pick Sep 13/11, Up 26.05%) Continues to do well. Still loves it.